17.10SEK+2.09%Mkt Cap: 30.99M $P/E: —1d ago
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap30.99M $
Enterprise Value14.25M $
Revenue (TTM)1.38M $
Gross Profit-161.94K $
Net Income (TTM)-17.46M $
Revenue/Share0.2075 USD
Last Price17.10 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees70
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011527845
Valuation
P/E (Trailing)—
P/E (Forward)-57.00
PEG—
EV/EBITDA-1.08
EV/Revenue10.31
P/S22.43
P/B1.18
EPS (TTM)-5.99
EPS (Forward)-0.30
52W Range
14.555% of range64.00
52W High64.00 SEK
52W Low14.55 SEK
Profitability
Gross Margin-15.26%
Oper. Margin-820.16%
EBITDA Margin0.00%
Profit Margin-1644.31%
ROE-53.99%
ROA-49.36%
Growth
Revenue Growth209.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.51M $
CapEx (TTM)723.23K $
FCF Margin-821.24%
FCF Yield-36.61%
Net Debt-16.75M $
Net Debt/EBITDA1.27
Balance Sheet
Debt/Equity0.02
Current Ratio117.99
Quick Ratio85.48
Book Value/Sh14.50 SEK
Cash/Share9.857 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateJul 14, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.95M
Float11.64M
Insiders13.96%
Institutions26.34%
Technical
SMA 5017.52 (-2.4%)
SMA 20022.52 (-24.1%)
Beta0.57
S&P 52W Chg19.63%
Avg Vol (30d)6.65K
Avg Vol (10d)5.95K
Technical Indicators
RSI (14)47.3
MACD-0.3459
MACD Signal-0.3616
MACD Hist.+0.0157
BB Upper18.24 SEK
BB Middle17.18 SEK
BB Lower16.13 SEK
BB Width12.26%
ATR (14)0.9437 SEK
Vol Ratio (20d)0.63x